{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:40:50Z","timestamp":1792006850415,"version":"4.4.0"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["NO.tstp20240848"],"award-info":[{"award-number":["NO.tstp20240848"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejphar.2026.179174","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:11:05Z","timestamp":1785071465000},"page":"179174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pulmonary fibrosis and the TGF-\u03b2 signaling axis: Advances in targeted therapeutics"],"prefix":"10.1016","volume":"1031","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejphar.2026.179174_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ncb826","article-title":"Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta","volume":"4","author":"Abreu","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"28","key":"10.1016\/j.ejphar.2026.179174_bib2","doi-asserted-by":"crossref","first-page":"eaba1983","DOI":"10.1126\/sciadv.aba1983","article-title":"Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis","volume":"6","author":"Adams","year":"2020","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib3","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2741\/3957","article-title":"The Wnt signaling pathways and cell adhesion","volume":"17","author":"Amin","year":"2012","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"9","key":"10.1016\/j.ejphar.2026.179174_bib4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/17512433.2024.2396121","article-title":"Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)","volume":"17","author":"Aribindi","year":"2024","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179174_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fmolb.2020.00128","article-title":"The post-translational modifications of Smurf2 in TGF-\u03b2 signaling","volume":"7","author":"Bai","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejphar.2026.179174_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1549277","article-title":"PI3K\/Akt in IPF: untangling fibrosis and charting therapies","volume":"16","author":"Bhatt","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179174_bib7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF-\u03b2 signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"},{"issue":"18","key":"10.1016\/j.ejphar.2026.179174_bib8","first-page":"1413","article-title":"Transforming growth factor-\u03b2-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis","volume":"38","author":"Blyszczuk","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2026.179174_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mam.2018.08.004","article-title":"Developmental pathways in the pathogenesis of lung fibrosis","volume":"65","author":"Chanda","year":"2019","journal-title":"Mol. Aspect. Med."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179174_bib10","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3390\/nu15061487","article-title":"Leaf extract of Perilla frutescens (L.) Britt promotes adipocyte browning via the p38 MAPK pathway and PI3K-AKT pathway","volume":"15","author":"Chen","year":"2023","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.ejphar.2026.179174_bib11","article-title":"The mRNA-binding protein DDX3 mediates TGF-\u03b21 upregulation of translation and promotes pulmonary fibrosis","volume":"8","author":"Chen","year":"2023","journal-title":"Journal of Clinical Investigation Insight"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.yexmp.2016.04.003","article-title":"Inhibition of Wnt\/\u03b2-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-\u03b21 and FGF-2","volume":"101","author":"Chen","year":"2016","journal-title":"Exp. Mol. Pathol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179174_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/0960327119895549","article-title":"Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-\u03b2\/Smad pathway","volume":"39","author":"Chen","year":"2020","journal-title":"Hum. Exp. Toxicol."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179174_bib14","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41401-024-01235-6","article-title":"Transforming growth factor-\u03b2 receptors: versatile mechanisms of ligand activation","volume":"45","author":"Chia","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179174_bib15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/ph17060709","article-title":"Pirfenidone and nintedanib in pulmonary fibrosis: lights and Shadows","volume":"17","author":"Chianese","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejphar.2026.179174_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104304","article-title":"A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis","volume":"85","author":"Chioccioli","year":"2022","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.ejphar.2026.179174_bib17","first-page":"549","article-title":"Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung","volume":"56","author":"Coker","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2026.179174_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejps.2014.02.014","article-title":"Effect of pirfenidone on proliferation, TGF-\u03b2-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts","volume":"58","author":"Conte","year":"2014","journal-title":"Eur. J. Pharmaceut. Sci.: Official Journal of the European Federation for Pharmaceutical Sciences"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1164\/rccm.202405-0977OC","article-title":"Efficacy and safety of admilparant, an LPA1 antagonist, in pulmonary fibrosis: a phase 2 randomized clinical trial","volume":"211","author":"Corte","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/BJ20100323","article-title":"Mechanisms and functions of p38 MAPK signalling","volume":"429","author":"Cuadrado","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2026.179174_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112096","article-title":"\u03b2-carboline alkaloids attenuate bleomycin induced pulmonary fibrosis in mice through inhibiting NF-kb\/p65 phosphorylation and epithelial-mesenchymal transition","volume":"243","author":"Cui","year":"2019","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2119\/molmed.2013.00123","article-title":"Transforming growth factor-\u03b21 downregulates vascular endothelial growth factor-D expression in human lung fibroblasts via the Jun NH2-terminal kinase signaling pathway","volume":"20","author":"Cui","year":"2014","journal-title":"Mol. Med. (Camb.)"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179174_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1123366","article-title":"Combined inhibition of TGF\u03b2 and PDGF signaling attenuates radiation-induced pulmonary fibrosis","volume":"5","author":"Dadrich","year":"2015","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179174_bib24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jcb.20458","article-title":"Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways","volume":"95","author":"Davies","year":"2005","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12931-021-01863-0","article-title":"Dual inhibition of \u03b1v\u03b26 and \u03b1v\u03b21 reduces fibrogenesis in lung tissue explants from patients with IPF","volume":"22","author":"Decaris","year":"2021","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib26","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1159\/000430268","article-title":"Platelet-derived growth factor and transforming growth factor \u03b21 regulate ARDS-associated lung fibrosis through distinct signaling pathways","volume":"36","author":"Deng","year":"2015","journal-title":"Cell. Physiol. Biochem. : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179174_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ncb975","article-title":"Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover","volume":"5","author":"Di Guglielmo","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179174_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.762998","article-title":"Wenfei Buqi Tongluo formula against bleomycin-induced pulmonary fibrosis by inhibiting TGF-\u03b2\/Smad3 pathway","volume":"12","author":"Ding","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"16","key":"10.1016\/j.ejphar.2026.179174_bib29","first-page":"1596","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"381","author":"Distler","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1172\/JCI29293","article-title":"The type III TGF-beta receptor suppresses breast cancer progression","volume":"117","author":"Dong","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179174_bib31","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1164\/rccm.201105-0840OC","article-title":"Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference","volume":"184","author":"Du Bois","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"13","key":"10.1016\/j.ejphar.2026.179174_bib32","first-page":"1774","article-title":"Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP","volume":"13","author":"Duncan","year":"1999","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J.: Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0014-4827(02)00015-0","article-title":"TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins","volume":"282","author":"Evans","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejphar.2026.179174_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118399","article-title":"Endogenous tryptophan metabolite 5-methoxytryptophan inhibits pulmonary fibrosis by downregulating the TGF-\u03b2\/SMAD3 and PI3K\/AKT signaling pathway","volume":"260","author":"Fang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2026.179174_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","article-title":"Specificity and versatility in tgf-beta signaling through Smads","volume":"21","author":"Feng","year":"2005","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"36","key":"10.1016\/j.ejphar.2026.179174_bib36","doi-asserted-by":"crossref","first-page":"27650","DOI":"10.1074\/jbc.M000893200","article-title":"Transforming growth factor-beta 1-induced activation of the ERK pathway\/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor","volume":"275","author":"Finlay","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib37","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04538-2020","article-title":"Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial","volume":"59","author":"Flaherty","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.0959-9673.2004.00377.x","article-title":"Smad3 as a mediator of the fibrotic response","volume":"85","author":"Flanders","year":"2004","journal-title":"Int. J. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib39","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179174_bib40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1165\/rcmb.2012-0262OC","article-title":"Reversal of myofibroblast differentiation by prostaglandin E(2)","volume":"48","author":"Garrison","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179174_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008692","article-title":"Loss of FOXM1 in macrophages promotes pulmonary fibrosis by activating p38 MAPK signaling pathway","volume":"16","author":"Goda","year":"2020","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ejphar.2026.179174_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-62703-791-4_1","article-title":"The Ras superfamily of small GTPases: the unlocked secrets","volume":"1120","author":"Goitre","year":"2014","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179174_bib43","first-page":"4223","article-title":"Crosstalk between TGF-\u03b21 and complement activation augments epithelial injury in pulmonary fibrosis","volume":"28","author":"Gu","year":"2014","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J.: Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib44","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/ijms21020524","article-title":"Idiopathic pulmonary fibrosis: pathogenesis and the emerging role of long non-coding RNAs","volume":"21","author":"Hadjicharalambous","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179174_bib45","article-title":"Engineering of stimulus-responsive pirfenidone liposomes for pulmonary delivery during treatment of idiopathic pulmonary fibrosis","volume":"13","author":"Han","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1164\/ajrccm.163.1.2005069","article-title":"Transforming growth factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway","volume":"163","author":"Hashimoto","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179174_bib47","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022053","article-title":"Signaling receptors for TGF-\u03b2 family members","volume":"8","author":"Heldin","year":"2016","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"32","key":"10.1016\/j.ejphar.2026.179174_bib48","doi-asserted-by":"crossref","first-page":"14309","DOI":"10.1073\/pnas.1001520107","article-title":"Inhibition of Wnt\/beta-catenin\/CREB binding protein (CBP) signaling reverses pulmonary fibrosis","volume":"107","author":"Henderson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"14","key":"10.1016\/j.ejphar.2026.179174_bib49","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1074\/jbc.M010149200","article-title":"CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling","volume":"276","author":"Holmes","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41392-024-02011-y","article-title":"Overexpression of STX11 alleviates pulmonary fibrosis by inhibiting fibroblast activation via the PI3K\/AKT\/mTOR pathway","volume":"9","author":"Huang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11033-023-09140-7","article-title":"Molecular basis and current insights of atypical rho small GTPase in cancer","volume":"51","author":"Huang","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"Pt 1","key":"10.1016\/j.ejphar.2026.179174_bib52","article-title":"ShaShen-MaiDong decoction attenuates bleomycin-induced pulmonary fibrosis by inhibiting TGF-\u03b2\/smad3, AKT\/MAPK, and YAP\/TAZ pathways","volume":"337","author":"Huang","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib53","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.00185114","article-title":"Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review","volume":"46","author":"Hutchinson","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179174_bib54","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/aps.2016.36","article-title":"Paeoniflorin suppresses TGF-\u03b2 mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway","volume":"37","author":"Ji","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179174_bib55","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.3390\/ijms13078293","article-title":"Fasudil, a Rho-kinase inhibitor, attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"13","author":"Jiang","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179174_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12124","article-title":"Human bronchial epithelial cell-derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF-\u03b2-WNT crosstalk","volume":"10","author":"Kadota","year":"2021","journal-title":"J. Extracell. Vesicles"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib57","first-page":"713","article-title":"Multi-layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT\/\u03b2-catenin signaling activation","volume":"42","author":"Katoh","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13045-021-01053-x","article-title":"Novel therapies emerging in oncology to target the TGF-\u03b2 pathway","volume":"14","author":"Kim","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"22","key":"10.1016\/j.ejphar.2026.179174_bib59","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib60","doi-asserted-by":"crossref","first-page":"L190","DOI":"10.1152\/ajplung.00086.2022","article-title":"Myofibroblast-specific inhibition of the Rho kinase-MRTF-SRF pathway using nanotechnology for the prevention of pulmonary fibrosis","volume":"324","author":"Knipe","year":"2023","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib61","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/pr.114.009381","article-title":"The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis","volume":"67","author":"Knipe","year":"2015","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib62","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.yexcr.2005.08.008","article-title":"Sequential deposition of latent TGF-beta binding proteins (LTBPs) during formation of the extracellular matrix in human lung fibroblasts","volume":"310","author":"Koli","year":"2005","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4161\/org.4.2.5851","article-title":"Wnt signal transduction pathways","volume":"4","author":"Komiya","year":"2008","journal-title":"Organogenesis"},{"issue":"12","key":"10.1016\/j.ejphar.2026.179174_bib64","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.molmed.2023.08.010","article-title":"Pulmonary fibrosis: from pathogenesis to clinical decision-making","volume":"29","author":"Koudstaal","year":"2023","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12931-024-02855-6","article-title":"Precision cut lung slices: an integrated ex vivo model for studying lung physiology, pharmacology, disease pathogenesis and drug discovery","volume":"25","author":"Koziol-White","year":"2024","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib66","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3390\/ijms22031073","article-title":"Machine learning analysis of longevity-associated gene expression landscapes in mammals","volume":"22","author":"Kulaga","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179174_bib67","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1164\/rccm.202403-0636OC","article-title":"Bexotegrast in patients with idiopathic pulmonary fibrosis: the INTEGRIS-IPF clinical trial","volume":"210","author":"Lancaster","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"20","key":"10.1016\/j.ejphar.2026.179174_bib68","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1038\/sj.emboj.7600386","article-title":"Endoglin promotes endothelial cell proliferation and TGF-beta\/ALK1 signal transduction","volume":"23","author":"Lebrin","year":"2004","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179174_bib69","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12272-022-01384-4","article-title":"Adapalene induces adipose browning through the RAR\u03b2-p38 MAPK-ATF2 pathway","volume":"45","author":"Lee","year":"2022","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"16","key":"10.1016\/j.ejphar.2026.179174_bib70","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1111\/jcmm.17478","article-title":"Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF-\u03b21\/Smad3 signalling pathway","volume":"26","author":"Li","year":"2022","journal-title":"J. Cell Mol. Med."},{"issue":"19","key":"10.1016\/j.ejphar.2026.179174_bib71","doi-asserted-by":"crossref","first-page":"11318","DOI":"10.1111\/jcmm.15713","article-title":"Long non-coding RNA ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the Wnt\/\u03b2-catenin signalling pathway and is a potential diagnostic biomarker","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib72","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/jcmm.17665","article-title":"Duvelisib attenuates bleomycin-induced pulmonary fibrosis via inhibiting the PI3K\/Akt\/mTOR signalling pathway","volume":"27","author":"Li","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2026.179174_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114097","article-title":"Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-\u03b2 signaling via targeting HSP90\u03b2","volume":"178","author":"Li","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib74","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12890-024-03260-x","article-title":"IL-10 deficiency aggravates cell senescence and accelerates BLM-induced pulmonary fibrosis in aged mice via PTEN\/AKT\/ERK pathway","volume":"24","author":"Li","year":"2024","journal-title":"BMC Pulm. Med."},{"issue":"15","key":"10.1016\/j.ejphar.2026.179174_bib75","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.3390\/ijms25158392","article-title":"Highlights on future treatments of IPF: clues and Pitfalls","volume":"25","author":"Libra","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179174_bib76","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.taap.2016.08.004","article-title":"Salvianolic acid B protects against paraquat-induced pulmonary injury by mediating Nrf2\/Nox4 redox balance and TGF-\u03b21\/Smad3 signaling","volume":"309","author":"Liu","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"29","key":"10.1016\/j.ejphar.2026.179174_bib77","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.18632\/oncotarget.27677","article-title":"Baicalin inhibits the TGF-\u03b21\/p-Smad3 pathway to suppress epithelial-mesenchymal transition-induced metastasis in breast cancer","volume":"11","author":"Liu","year":"2020","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib78","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12931-020-1300-y","article-title":"Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-\u03b2-induced fibroblast to myofibroblast differentiation","volume":"21","author":"Liu","year":"2020","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179174_bib79","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1165\/rcmb.2020-0499OC","article-title":"Noncanonical Wnt signaling promotes myofibroblast differentiation in pulmonary fibrosis","volume":"65","author":"Liu","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib80","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ydbio.2019.02.010","article-title":"MiR-124 regulates transforming growth factor-\u03b21 induced differentiation of lung resident mesenchymal stem cells to myofibroblast by repressing Wnt\/\u03b2-catenin signaling","volume":"449","author":"Lu","year":"2019","journal-title":"Dev. Biol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib81","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01992-2018","article-title":"A randomised, placebo-controlled study of omipalisib (PI3K\/mTOR) in idiopathic pulmonary fibrosis","volume":"53","author":"Lukey","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib82","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41419-025-07573-5","article-title":"Inhibition of Rho GEFs attenuates pulmonary fibrosis through suppressing myofibroblast activation and reprogramming profibrotic macrophages","volume":"16","author":"Luo","year":"2025","journal-title":"Cell Death Dis."},{"issue":"19","key":"10.1016\/j.ejphar.2026.179174_bib83","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.4155\/fmc-2019-0111","article-title":"Current advances in idiopathic pulmonary fibrosis: the pathogenesis, therapeutic strategies and candidate molecules","volume":"11","author":"Lv","year":"2019","journal-title":"Future Med. Chem."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179174_bib84","first-page":"1639","article-title":"Shensiqigui tablets alleviate bleomycin-induced pulmonary fibrosis by inhibiting the hedgehog\/wnt-\u03b2-catenin pathway","volume":"40","author":"Ma","year":"2025","journal-title":"Histol. Histopathol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib85","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1165\/rcmb.2011-0237OC","article-title":"MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation","volume":"46","author":"Madala","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib86","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","article-title":"Global incidence and prevalence of idiopathic pulmonary fibrosis","volume":"22","author":"Maher","year":"2021","journal-title":"Respir. Res."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179174_bib87","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1101\/gad.12.10.1438","article-title":"Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite","volume":"12","author":"McMahon","year":"1998","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179174_bib88","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"525","key":"10.1016\/j.ejphar.2026.179174_bib89","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay4860","article-title":"Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-\u03b2","volume":"12","author":"Metelli","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib90","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K","article-title":"Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model","volume":"181","author":"Mori","year":"1999","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib91","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02441-2018","article-title":"Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis","volume":"54","author":"Morse","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009683","article-title":"Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages","volume":"5","author":"Murray","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179174_bib93","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.biopha.2017.09.023","article-title":"Shikonin suppresses pulmonary fibroblasts proliferation and activation by regulating Akt and p38 MAPK signaling pathways","volume":"95","author":"Nie","year":"2017","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.ejphar.2026.179174_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117285","article-title":"Tryptanthrin alleviate lung fibrosis via suppression of MAPK\/NF-\u03baB and TGF-\u03b21\/SMAD signaling pathways in vitro and in vivo","volume":"498","author":"Niu","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib95","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1183\/13993003.00026-2015","article-title":"Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials","volume":"47","author":"Noble","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179174_bib96","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1083\/jcb.136.5.1151","article-title":"Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta","volume":"136","author":"Nunes","year":"1997","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib97","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41467-018-03962-x","article-title":"TGF-\u03b2 induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression","volume":"9","author":"Ottaviani","year":"2018","journal-title":"Nat. Commun."},{"issue":"5715","key":"10.1016\/j.ejphar.2026.179174_bib98","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.1105718","article-title":"Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity","volume":"307","author":"Ozdamar","year":"2005","journal-title":"Science (New York, N.Y.)"},{"issue":"9","key":"10.1016\/j.ejphar.2026.179174_bib99","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1172\/JCI135439","article-title":"Long noncoding RNA H19X is a key mediator of TGF-\u03b2-driven fibrosis","volume":"130","author":"Pachera","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179174_bib100","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.chest.2021.06.049","article-title":"Impact of antifibrotic therapy on mortality and acute exacerbation in idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"160","author":"Petnak","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2026.179174_bib101","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejpb.2023.05.017","article-title":"Baicalin\/ambroxol hydrochloride combined dry powder inhalation formulation targeting lung delivery for treatment of idiopathic pulmonary fibrosis: fabrication, characterization, pharmacokinetics, and pharmacodynamics","volume":"188","author":"Qi","year":"2023","journal-title":"Eur. J. Pharm. Biopharm.: Official Journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib102","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2023.2195305","article-title":"LncRNA TUG1 promotes pulmonary fibrosis progression via up-regulating CDC27 and activating PI3K\/Akt\/mTOR pathway","volume":"18","author":"Qi","year":"2023","journal-title":"Epigenetics"},{"issue":"9","key":"10.1016\/j.ejphar.2026.179174_bib103","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1164\/rccm.202112-2824OC","article-title":"A phase IIb randomized clinical study of an anti-\u03b1v\u03b26 monoclonal antibody in idiopathic pulmonary fibrosis","volume":"206","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179174_bib104","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179174_bib105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jama.2024.8693","article-title":"Pamrevlumab for idiopathic pulmonary fibrosis: the ZEPHYRUS-1 randomized clinical trial","volume":"332","author":"Raghu","year":"2024","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ejphar.2026.179174_bib106","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4049\/immunohorizons.1900046","article-title":"Aspergillus fumigatus-secreted alkaline protease 1 mediates airways hyperresponsiveness in severe asthma","volume":"3","author":"Redes","year":"2019","journal-title":"ImmunoHorizons"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib107","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41587-024-02143-0","article-title":"A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models","volume":"43","author":"Ren","year":"2025","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179174_bib108","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.14336\/AD.2023.0222","article-title":"TGF-\u03b2 as a master regulator of aging-associated tissue fibrosis","volume":"14","author":"Ren","year":"2023","journal-title":"Aging and Disease"},{"issue":"22","key":"10.1016\/j.ejphar.2026.179174_bib109","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1056\/NEJMoa2414108","article-title":"Nerandomilast in patients with idiopathic pulmonary fibrosis","volume":"392","author":"Richeldi","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-2600(19)30262-0","article-title":"Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"8","author":"Richeldi","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"1 Suppl. l","key":"10.1016\/j.ejphar.2026.179174_bib111","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1016\/S0012-3692(15)38703-1","article-title":"Is Smad3 a major player in signal transduction pathways leading to fibrogenesis?","volume":"120","author":"Roberts","year":"2001","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056587","article-title":"An integrated expression profiling reveals target genes of TGF-\u03b2 and TNF-\u03b1 possibly mediated by microRNAs in lung cancer cells","volume":"8","author":"Saito","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib113","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/ijms22031003","article-title":"p38 signalling pathway","volume":"22","author":"Sanz-Ezquerro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib114","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jdermsci.2003.12.006","article-title":"TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing","volume":"35","author":"Schiller","year":"2004","journal-title":"J. Dermatol. Sci."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179174_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047344","article-title":"Neurally mediated airway constriction in human and other species: a comparative study using precision-cut lung slices (PCLS)","volume":"7","author":"Schlep\u00fctz","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib116","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1124\/jpet.105.091249","article-title":"Transforming growth factor-beta-dependent growth inhibition in primary vascular smooth muscle cells is p38-dependent","volume":"315","author":"Seay","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib117","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1113\/JP275033","article-title":"Transforming growth factor-\u03b2 enhances Rho-kinase activity and contraction in airway smooth muscle via the nucleotide exchange factor ARHGEF1","volume":"596","author":"Shaifta","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2026.179174_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175820","article-title":"Dehydrozingerone alleviates pulmonary fibrosis via inhibition of inflammation and epithelial-mesenchymal transition by regulating the Wnt\/\u03b2-catenin pathway","volume":"953","author":"Shaikh","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib119","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12026-022-09267-y","article-title":"Research progress on drugs targeting the TGF-\u03b2 signaling pathway in fibrotic diseases","volume":"70","author":"Shi","year":"2022","journal-title":"Immunol. Res."},{"issue":"22","key":"10.1016\/j.ejphar.2026.179174_bib120","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1101\/gad.1360605","article-title":"TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo","volume":"19","author":"Shim","year":"2005","journal-title":"Genes Dev."},{"issue":"38","key":"10.1016\/j.ejphar.2026.179174_bib121","doi-asserted-by":"crossref","first-page":"29308","DOI":"10.1074\/jbc.M003282200","article-title":"Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. The TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation","volume":"275","author":"Stopa","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib122","first-page":"145","article-title":"The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo","volume":"5","author":"Sullivan","year":"2008","journal-title":"J. Immunot."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib123","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1186\/s12967-024-05289-2","article-title":"Lactate facilitated mitochondrial fission-derived ROS to promote pulmonary fibrosis via ERK\/DRP-1 signaling","volume":"22","author":"Sun","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.179174_bib124","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.toxlet.2020.08.004","article-title":"Paraquat induces pulmonary fibrosis through Wnt\/\u03b2-catenin signaling pathway and myofibroblast differentiation","volume":"333","author":"Sun","year":"2020","journal-title":"Toxicol. Lett."},{"issue":"187","key":"10.1016\/j.ejphar.2026.179174_bib125","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.24976\/Discov.Med.202436187.148","article-title":"USP7 promotes TGF-\u03b21 signaling by de-ubiquitinating Smad2\/Smad3 in pulmonary fibrosis","volume":"36","author":"Tang","year":"2024","journal-title":"Discov. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib126","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1755-1536-5-11","article-title":"Molecular and cellular mechanisms of pulmonary fibrosis","volume":"5","author":"Todd","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib127","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98674-6","article-title":"Systems biology analysis of lung fibrosis-related genes in the bleomycin mouse model","volume":"11","author":"Toren","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179174_bib128","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/cells10051034","article-title":"Next generation therapeutics for the treatment of myelofibrosis","volume":"10","author":"Tremblay","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226904","article-title":"Airway epithelial specific deletion of Jun-N-terminal kinase 1 attenuates pulmonary fibrosis in two independent mouse models","volume":"15","author":"van der Velden","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40169-016-0117-2","article-title":"JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers","volume":"5","author":"van der Velden","year":"2016","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.179174_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663203","article-title":"Regulatory immune cells in idiopathic pulmonary fibrosis: friends or foes?","volume":"12","author":"van Geffen","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib132","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/nn5070343","article-title":"Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors","volume":"9","author":"van Rijt","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejphar.2026.179174_bib133","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cellsig.2018.09.002","article-title":"TGF-\u03b2 receptors: in and beyond TGF-\u03b2 signaling","volume":"52","author":"Vander Ark","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2026.179174_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101866","article-title":"Sinensetin protects against pulmonary fibrosis via inhibiting Wnt\/\u03b2-Catenin signaling pathway","volume":"78","author":"Wan","year":"2022","journal-title":"Tissue Cell"},{"key":"10.1016\/j.ejphar.2026.179174_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2020.110253","article-title":"Exosomal miR-125a-5p derived from silica-exposed macrophages induces fibroblast transdifferentiation","volume":"192","author":"Wang","year":"2020","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib136","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5603\/FHC.a2022.0022","article-title":"HIPK2 attenuates bleomycin-induced pulmonary fibrosis by suppressing the Wnt\/\u03b2-catenin signaling pathway","volume":"60","author":"Wang","year":"2022","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.ejphar.2026.179174_bib137","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biopha.2018.05.104","article-title":"Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK\/AP-1 pathways","volume":"105","author":"Wang","year":"2018","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib138","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","article-title":"Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2026.179174_bib139","article-title":"Monomeric compounds from traditional Chinese medicine: new hopes for drug discovery in pulmonary fibrosis","volume":"159","author":"Wang","year":"2023","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.ejphar.2026.179174_bib140","article-title":"Regulation of idiopathic pulmonary fibrosis: a cross-talk between TGF-\u03b2 signaling and MicroRNAs","volume":"11","author":"Wang","year":"2024","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib141","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yexcr.2018.01.019","article-title":"Elongation factor-2 kinase acts downstream of p38 MAPK to regulate proliferation, apoptosis and autophagy in human lung fibroblasts","volume":"363","author":"Wang","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib142","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cardiores.2005.11.007","article-title":"A direct interaction between TGFbeta activated kinase 1 and the TGFbeta type II receptor: implications for TGFbeta signalling and cardiac hypertrophy","volume":"69","author":"Watkins","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179174_bib143","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41419-019-1873-x","article-title":"Transforming growth factor (TGF)-\u03b21-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis","volume":"10","author":"Wei","year":"2019","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.ejphar.2026.179174_bib144","first-page":"6252","article-title":"MiR-340-5p mitigates the proliferation and activation of fibroblast in lung fibrosis by targeting TGF-\u03b2\/p38\/ATF1 signaling pathway","volume":"24","author":"Wei","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179174_bib145","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/thorax-2022-219391","article-title":"Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial","volume":"78","author":"West","year":"2023","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179174_bib146","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ceb.2007.02.001","article-title":"The JNK signal transduction pathway","volume":"19","author":"Weston","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"issue":"23","key":"10.1016\/j.ejphar.2026.179174_bib147","doi-asserted-by":"crossref","first-page":"8878","DOI":"10.1128\/MCB.23.23.8878-8889.2003","article-title":"Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3","volume":"23","author":"Wilkes","year":"2003","journal-title":"Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179174_bib148","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s40262-019-00766-0","article-title":"Clinical pharmacokinetics and pharmacodynamics of nintedanib","volume":"58","author":"Wind","year":"2019","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib149","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41467-018-07858-8","article-title":"The mTORC1\/4E-BP1 axis represents a critical signaling node during fibrogenesis","volume":"10","author":"Woodcock","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1947601911407328","article-title":"The ERK cascade: distinct functions within various subcellular organelles","volume":"2","author":"Wortzel","year":"2011","journal-title":"Genes Cancer"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib151","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12890-023-02747-3","article-title":"A selective CB2R agonist (JWH133) protects against pulmonary fibrosis through inhibiting FAK\/ERK\/S100A4 signaling pathways","volume":"23","author":"Wu","year":"2023","journal-title":"BMC Pulm. Med."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179174_bib153","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1021\/acs.jmedchem.2c01753","article-title":"Application and study of ROCK inhibitors in pulmonary fibrosis: recent developments and future perspectives","volume":"66","author":"Xie","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179174_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.590972","article-title":"Therapeutic potential of exosomes in pulmonary fibrosis","volume":"11","author":"Xie","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179174_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107780","article-title":"Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice via the JNK and p38 MAPK-mediated NF-\u03baB signaling pathways","volume":"98","author":"Xiong","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2026.179174_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112354","article-title":"Synthesis and biological evaluation of 4-(pyridin-4-oxy)-3-(3,3-difluorocyclobutyl)-pyrazole derivatives as novel potent transforming growth factor-\u03b2 type 1 receptor inhibitors","volume":"198","author":"Xu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejphar.2026.179174_bib156","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184158","article-title":"PIEZO1 mediates periostin+ myofibroblast activation and pulmonary fibrosis in mice","volume":"135","author":"Xu","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib157","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41392-025-02142-w","article-title":"Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances","volume":"10","author":"Xue","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179174_bib158","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1002\/ptr.7253","article-title":"Combination therapy of tanshinone IIA and puerarin for pulmonary fibrosis via targeting IL6-JAK2-STAT3\/STAT1 signaling pathways","volume":"35","author":"Xue","year":"2021","journal-title":"Phytother Res.: PT"},{"key":"10.1016\/j.ejphar.2026.179174_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.594139","article-title":"Catalpol protects against pulmonary fibrosis through inhibiting TGF-\u03b21\/Smad3 and Wnt\/\u03b2-Catenin signaling pathways","volume":"11","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179174_bib161","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179174_bib162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0255-x","article-title":"microRNA-328 in exosomes derived from M2 macrophages exerts a promotive effect on the progression of pulmonary fibrosis via FAM13A in a rat model","volume":"51","author":"Yao","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib163","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3892\/ijmm.2021.4965","article-title":"TGF-\u03b21: gentlemanly orchestrator in idiopathic pulmonary fibrosis","volume":"48","author":"Ye","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib164","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12931-024-02989-7","article-title":"SPP1 induces idiopathic pulmonary fibrosis and NSCLC progression via the PI3K\/Akt\/mTOR pathway","volume":"25","author":"Yue","year":"2024","journal-title":"Respir. Res."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179174_bib165","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1073\/pnas.111614398","article-title":"Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta","volume":"98","author":"Zavadil","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib166","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-beta signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.ejphar.2026.179174_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2015.01.001","article-title":"TGF\u03b21 rapidly activates Src through a non-canonical redox signaling mechanism","volume":"568","author":"Zhang","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2026.179174_bib168","article-title":"Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: rationale and therapeutic potential","volume":"133","author":"Zhang","year":"2021","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.ejphar.2026.179174_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117737","article-title":"Leech extract alleviates idiopathic pulmonary fibrosis by TGF-\u03b21\/Smad3 signaling pathway","volume":"324","author":"Zhang","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib170","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54433-5","article-title":"A stepwise mode of TGF\u03b2-SMAD signaling and DNA methylation regulates na\u00efve-to-primed pluripotency and differentiation","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179174_bib171","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12951-023-02251-0","article-title":"Traditional Chinese medicine inspired dual-drugs loaded inhalable nano-therapeutics alleviated idiopathic pulmonary fibrosis by targeting early inflammation and late fibrosis","volume":"22","author":"Zheng","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179174_bib172","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/cbf.1464","article-title":"Using RNA interference to identify the different roles of SMAD2 and SMAD3 in NIH\/3T3 fibroblast cells","volume":"26","author":"Zheng","year":"2008","journal-title":"Cell Biochem. Funct."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179174_bib173","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.molcel.2012.12.002","article-title":"c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-\u03b2 type II receptor","volume":"49","author":"Zuo","year":"2013","journal-title":"Mol. Cell"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:16:37Z","timestamp":1786652197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926006564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":173,"alternative-id":["S0014299926006564"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179174","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary fibrosis and the TGF-\u03b2 signaling axis: Advances in targeted therapeutics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179174"}}